Development of Artificial Intelligence Tools for the Detection of Stress Markers and Consideration of Stress States in the Monitoring of Subjects With Type 1 Diabetes

Launched by CENTRE D'ETUDES ET DE RECHERCHE POUR L'INTENSIFICATION DU TRAITEMENT DU DIABÈTE · May 21, 2025

Keywords

ClinConnect Summary

The SMART-T1D study is focused on developing new tools that use artificial intelligence (AI) to detect stress levels in people with Type 1 diabetes. Stress can significantly affect blood sugar control, with sudden (acute) stress causing quick increases in blood sugar levels and ongoing (chronic) stress leading to insulin resistance. By better understanding and measuring stress in diabetes patients, healthcare providers can offer more tailored treatments and improve patients’ overall quality of life.

To participate in this study, you need to be able to read and speak French and sign a consent form. Unfortunately, individuals who cannot speak or have serious speech difficulties that prevent voice recordings cannot join. If you are eligible, you can expect to help train AI algorithms using your voice and other physiological data to identify stress more accurately, which can lead to better management of diabetes. Note that the study is not yet open for recruiting participants.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient who has signed the SMART-T1D free and informed consent form
• • Patient able to speak and read French
• Exclusion Criteria:
• • Mute patient.
• • Patient with severe speech problems that may prevent voice recordings from being made.